Portion control: GLP-1 medications help reduce appetite, so smaller portions can be more satisfying
This scenario is especially common with compounded tirzepatide from larger pharmacies that may change their standard concentrations due to supply chain shifts
During shortages of Wegovy, Ozempic, Mounjaro, and Zepbound, the FDA exercised temporary enforcement discretion , allowing compounding pharmacies to help meet patient demand. Once manufacturing stabilized: Semaglutide injection products were removed from the FDA Drug Shortage List Tirzepatide injection products were formally declared resolved Compounding reverted to pre-shortage federal and state limits Broad, shortage-based compounding is no longer allowed in 2026
One cohort study indicated that diabetic patients using GLP-1 RAs had a lower likelihood of developing PD compared with those using other oral glucose-lowering medications
For those who meet certain income criteria, nonprofit organizations such as the Patient Access Network (PAN) Foundation offer financial aid to low-income or uninsured individuals
